ITI Pharma and Healthcare Fund Regular Growth

• Alpha 0.00%
• Beta 0.00
• Sharpe Ratio0.77
• Std Deviation 15.61%
• Tracking Error 0.00%

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

The ITI Pharma and Healthcare Fund Regular Growth has an AUM of 223.80 crores & has delivered CAGR of 0.00% in the last 5 years. The fund has an exit load of 0.50% and an expense ratio of 2.35%. The minimum investment in ITI Pharma and Healthcare Fund Regular Growth is Rs 5000 and the minimum SIP is Rs 500.

As per morningstar the risk & return rating of the fund are Medium & Exceptional respectively.

The top holdings of the fund include Sun Pharmaceutical Industries, Divi's Laboratories, Apollo Hospitals Enterprise & Max Healthcare Institute.

The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Major Drugs & Chemical Manufacturing.

Some of the similar funds are LIC MF Healthcare Fund Regular Growth, ITI Pharma and Healthcare Fund Regular Growth, Kotak Healthcare Fund Regular Growth, Quant Healthcare Fund Regular Growth, PGIM India Healthcare Fund Regular Growth. ITI Pharma and Healthcare Fund Regular Growth has a sharpe ratio of 0.77 & a standard deviation of 15.61%.